Financial report context:
notes to consolidated financial statements 2013 ( continued ) ( amounts in millions , except per share amounts ) the estimated future benefit payments expected to be paid are presented below . domestic pension plan foreign pension plans domestic postretirement benefit plan .

Financial table:
years: 2019; domesticpension plan: $ 14.5; foreignpension plans: $ 21.7; domestic postretirementbenefit plan: $ 3.0
years: 2020; domesticpension plan: 8.8; foreignpension plans: 18.7; domestic postretirementbenefit plan: 2.8
years: 2021; domesticpension plan: 8.0; foreignpension plans: 19.8; domestic postretirementbenefit plan: 2.6
years: 2022; domesticpension plan: 8.3; foreignpension plans: 20.9; domestic postretirementbenefit plan: 2.4
years: 2023; domesticpension plan: 7.8; foreignpension plans: 21.8; domestic postretirementbenefit plan: 2.2
years: 2024 - 2028; domesticpension plan: 36.7; foreignpension plans: 117.2; domestic postretirementbenefit plan: 9.8

Additional report context:
the estimated future payments for our domestic postretirement benefit plan are net of any estimated u.s . federal subsidies expected to be received under the medicare prescription drug , improvement and modernization act of 2003 , which total no more than $ 0.3 in any individual year . savings plans we sponsor defined contribution plans ( the 201csavings plans 201d ) that cover substantially all domestic employees . the savings plans permit participants to make contributions on a pre-tax and/or after-tax basis and allow participants to choose among various investment alternatives . we match a portion of participant contributions based upon their years of service . amounts expensed for the savings plans for 2018 , 2017 and 2016 were $ 52.6 , $ 47.2 and $ 47.0 , respectively . expenses include a discretionary company contribution of $ 6.7 , $ 3.6 and $ 6.1 offset by participant forfeitures of $ 5.8 , $ 4.6 and $ 4.4 in 2018 , 2017 and 2016 , respectively . in addition , we maintain defined contribution plans in various foreign countries and contributed $ 51.3 , $ 47.4 and $ 44.5 to these plans in 2018 , 2017 and 2016 , respectively . deferred compensation and benefit arrangements we have deferred compensation and benefit arrangements which ( i ) permit certain of our key officers and employees to defer a portion of their salary or incentive compensation or ( ii ) require us to contribute an amount to the participant 2019s account . these arrangements may provide participants with the amounts deferred plus interest upon attaining certain conditions , such as completing a certain number of years of service , attaining a certain age or upon retirement or termination . as of december 31 , 2018 and 2017 , the deferred compensation and deferred benefit liability balance was $ 196.2 and $ 213.2 , respectively . amounts expensed for deferred compensation and benefit arrangements in 2018 , 2017 and 2016 were $ 10.0 , $ 18.5 and $ 18.5 , respectively . we have purchased life insurance policies on participants 2019 lives to assist in the funding of the related deferred compensation and deferred benefit liabilities . as of december 31 , 2018 and 2017 , the cash surrender value of these policies was $ 177.3 and $ 177.4 , respectively . long-term disability plan we have a long-term disability plan which provides income replacement benefits to eligible participants who are unable to perform their job duties or any job related to his or her education , training or experience . as all income replacement benefits are fully insured , no related obligation is required as of december 31 , 2018 and 2017 . in addition to income replacement benefits , plan participants may remain covered for certain health and life insurance benefits up to normal retirement age , and accordingly , we have recorded an obligation of $ 5.9 and $ 8.4 as of december 31 , 2018 and 2017 , respectively. .

Question: what is the percentage decrease between the amounts expensed for deferred compensation and deferred benefit liability in 2017 and 2018?
Answer: 7.97